BeStock  
Stocks › Biotechnology › SLN

Silence Therapeutics SLN

US equityMarket cap rank #3610Biotechnology
$9.82 −$0.01 (-0.10%)
Pre-market · Oct 8, 8:20 am ET · After hours $9.82 0.00%
Open$9.77
Prev close$9.83
Day range$9.60 – $10.14
Volume1.32M
Market cap$610.35M
P/E (TTM)–
Dividend yield–

Analyst view

ConsensusBuy
Analysts5
Average target$37.00+276.8% vs. price
  • Buy 80%
  • Sell 20%
Low $4.00Now $9.82Avg $37.00High $75.00

Recent rating changes

The last 20 actions on file set price targets from $4.00 to $75.00, averaging $42.64.

DateFirmRatingTarget
21 Sep 2026 H.C. Wainwright BUY $75.00
10 Sep 2026 William Blair BUY –
16 Aug 2026 Chardan Capital BUY –
14 Aug 2026 H.C. Wainwright BUY $75.00
11 Aug 2026 Morgan Stanley BUY $32.00
11 Aug 2026 H.C. Wainwright BUY $75.00
10 Aug 2026 Chardan Capital BUY $27.00
10 Aug 2026 William Blair BUY –
10 Aug 2026 Morgan Stanley BUY $32.00
10 Aug 2026 H.C. Wainwright BUY $75.00
27 Jul 2026 Goldman Sachs SELL $4.00
24 Jun 2026 Cantor Fitzgerald BUY –
11 Jun 2026 William Blair BUY –
11 Jun 2026 Morgan Stanley BUY $25.00
2 Jun 2026 Morgan Stanley BUY $25.00
29 May 2026 Morgan Stanley BUY $25.00
7 May 2026 Chardan Capital BUY $27.00
29 Apr 2026 H.C. Wainwright BUY $75.00
6 Mar 2026 William Blair BUY –
6 Mar 2026 Morgan Stanley BUY $25.00

Discussion

No comments yet — be the first to weigh in on SLN.

Leave a comment

Scroll to Top